183 related articles for article (PubMed ID: 11780394)
21. Gene therapy of metastatic colon carcinoma: regression of multiple hepatic metastases by adenoviral expression of bacterial cytosine deaminase.
Block A; Freund CT; Chen SH; Nguyen KP; Finegold M; Windler E; Woo SL
Cancer Gene Ther; 2000 Mar; 7(3):438-45. PubMed ID: 10766350
[TBL] [Abstract][Full Text] [Related]
22. Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor.
Mullen CA; Coale MM; Lowe R; Blaese RM
Cancer Res; 1994 Mar; 54(6):1503-6. PubMed ID: 8137255
[TBL] [Abstract][Full Text] [Related]
23. In vivo adenoviral-mediated gene transfer in the treatment of pancreatic cancer.
Evoy D; Hirschowitz EA; Naama HA; Li XK; Crystal RG; Daly JM; Lieberman MD
J Surg Res; 1997 Apr; 69(1):226-31. PubMed ID: 9202675
[TBL] [Abstract][Full Text] [Related]
24. Quantitation of cytosine deaminase mRNA by real-time reverse transcription polymerase chain reaction: a sensitive method for assessing 5-fluorocytosine toxicity in vitro.
Miller CR; Gustin AN; Buchsbaum DJ; Vickers SM; Manne U; Grizzle WE; Cloud GA; Diasio RB; Johnson MR
Anal Biochem; 2002 Feb; 301(2):189-99. PubMed ID: 11814289
[TBL] [Abstract][Full Text] [Related]
25. Gene transfer into human prostate adenocarcinoma cells with an adenoviral vector: Hyperthermia enhances a double suicide gene expression, cytotoxicity and radiotoxicity.
Lee YJ; Lee H; Borrelli MJ
Cancer Gene Ther; 2002 Mar; 9(3):267-74. PubMed ID: 11896443
[TBL] [Abstract][Full Text] [Related]
26. Fractionated radiation therapy in combination with adenoviral delivery of the cytosine deaminase gene and 5-fluorocytosine enhances cytotoxic and antitumor effects in human colorectal and cholangiocarcinoma models.
Stackhouse MA; Pederson LC; Grizzle WE; Curiel DT; Gebert J; Haack K; Vickers SM; Mayo MS; Buchsbaum DJ
Gene Ther; 2000 Jun; 7(12):1019-26. PubMed ID: 10871750
[TBL] [Abstract][Full Text] [Related]
27. [Anticancer effects of cytosine deaminase gene/5-fluorocytosine therapies to ovarian cancer in vivo].
Yao Y; Peng Z; Wang H; Li Q; Liu S
Zhonghua Fu Chan Ke Za Zhi; 2002 Apr; 37(4):195-7. PubMed ID: 12133407
[TBL] [Abstract][Full Text] [Related]
28. Construction and testing of gene therapy retroviral vector expressing bacterial cytosine deaminase gene.
Hlavatý J; Hlubinová K; Altaner C
Neoplasma; 1999; 46(5):267-76. PubMed ID: 10665841
[TBL] [Abstract][Full Text] [Related]
29. Low-dose etoposide enhances telomerase-dependent adenovirus-mediated cytosine deaminase gene therapy through augmentation of adenoviral infection and transgene expression in a syngeneic bladder tumor model.
Shieh GS; Shiau AL; Yo YT; Lin PR; Chang CC; Tzai TS; Wu CL
Cancer Res; 2006 Oct; 66(20):9957-66. PubMed ID: 17047058
[TBL] [Abstract][Full Text] [Related]
30. Combined liposome-mediated cytosine deaminase gene therapy with radiation in killing rectal cancer cells and xenografts in athymic mice.
Li S; Yu B; An P; Chen G; Lu W; Cai H; Guo W; Zuo F
Clin Cancer Res; 2005 May; 11(9):3574-8. PubMed ID: 15867262
[TBL] [Abstract][Full Text] [Related]
31. Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil.
Kuriyama S; Masui K; Sakamoto T; Nakatani T; Kikukawa M; Tsujinoue H; Mitoro A; Yamazaki M; Yoshiji H; Fukui H; Ikenaka K; Mullen CA; Tsujii T
Anticancer Res; 1998; 18(5A):3399-406. PubMed ID: 9858915
[TBL] [Abstract][Full Text] [Related]
32. Replicating adenoviral vector-mediated transfer of a heat-inducible double suicide gene for gene therapy.
Lee YJ; Galoforo SS; Battle P; Lee H; Corry PM; Jessup JM
Cancer Gene Ther; 2001 Jun; 8(6):397-404. PubMed ID: 11498759
[TBL] [Abstract][Full Text] [Related]
33. Adenoviral vector containing wild-type p16 suppresses prostate cancer growth and prolongs survival by inducing cell senescence.
Steiner MS; Zhang Y; Farooq F; Lerner J; Wang Y; Lu Y
Cancer Gene Ther; 2000 Mar; 7(3):360-72. PubMed ID: 10766342
[TBL] [Abstract][Full Text] [Related]
34. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
Igawa T; Lin FF; Rao P; Lin MF
Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
[TBL] [Abstract][Full Text] [Related]
35. Enzyme/prodrug gene therapy approach for breast cancer using a recombinant adenovirus expressing Escherichia coli cytosine deaminase.
Li Z; Shanmugam N; Katayose D; Huber B; Srivastava S; Cowan K; Seth P
Cancer Gene Ther; 1997; 4(2):113-7. PubMed ID: 9080120
[TBL] [Abstract][Full Text] [Related]
36. Oncolytic adenoviral vector carrying the cytosine deaminase gene for melanoma gene therapy.
Liu Y; Deisseroth A
Cancer Gene Ther; 2006 Sep; 13(9):845-55. PubMed ID: 16710344
[TBL] [Abstract][Full Text] [Related]
37. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine.
Hirschowitz EA; Ohwada A; Pascal WR; Russi TJ; Crystal RG
Hum Gene Ther; 1995 Aug; 6(8):1055-63. PubMed ID: 7578418
[TBL] [Abstract][Full Text] [Related]
38. Tumor-specific intravenous gene delivery using oncolytic adenoviruses.
Zhan J; Gao Y; Wang W; Shen A; Aspelund A; Young M; Laquerre S; Post L; Shen Y
Cancer Gene Ther; 2005 Jan; 12(1):19-25. PubMed ID: 15514685
[TBL] [Abstract][Full Text] [Related]
39. In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase.
Chung-Faye GA; Chen MJ; Green NK; Burton A; Anderson D; Mautner V; Searle PF; Kerr DJ
Gene Ther; 2001 Oct; 8(20):1547-54. PubMed ID: 11704815
[TBL] [Abstract][Full Text] [Related]
40. KDR promoter can transcriptionally target cytosine deaminase suicide gene to cancer cells of nonendothelial origin.
Szary J; Kalita K; Przybyszewska M; Dus D; Kieda C; Janik P; Szala S
Anticancer Res; 2001; 21(5):3471-5. PubMed ID: 11848511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
